128 results
Page 5 of 7
424B3
EX-10.2
g2esq
2 Nov 17
Prospectus supplement
12:00am
8-K
EX-10.1
bbi185eww
2 Nov 17
Nemus Bioscience Announces $2,000,000 Series F Preferred Stock Financing
12:00am
424B3
EX-10.1
011e505m
2 Nov 17
Prospectus supplement
12:00am
424B3
EX-10.1
viz92 6jt9ti0a2
12 May 17
Prospectus supplement
12:00am
8-K
EX-10.1
iw314
4 May 17
Nemus Bioscience Announces $20 Million Series E
12:00am
424B3
EX-10.1
nl7pjb45 s979
20 Jan 17
Prospectus supplement
12:00am
424B3
EX-10
ififp1if
20 Jan 17
Prospectus supplement
12:00am
8-K/A
EX-10.1
amtr49c
20 Jan 17
Financial Statements and Exhibits
12:00am
8-K
EX-10.1
3qtemv469
10 Jan 17
NEMUS Bioscience Announces Closing of $1,200,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
1venpxy8b izqqz
29 Dec 16
Nemus Bioscience Announces Preferred Stock Financing
12:00am
8-K
EX-10.1
r1stjyr96ob 0t
29 Dec 16
Nemus Bioscience Announces Preferred Stock Financing
12:00am
424B3
EX-10.1
zf8kwm r22gk
28 Oct 16
Prospectus supplement
12:00am
8-K
EX-10.1
102jmqa25s4 8d0b6v
27 Oct 16
NEMUS Bioscience Announces Closing of $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.1
x1fkfl
26 Oct 16
NEMUS Bioscience Announces $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
mf58xlr
26 Oct 16
NEMUS Bioscience Announces $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.1
wvcd 7im4rzo
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
xyo0vloyckro10xq05j
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
fx8rq3nmhtgxhz nwnqp
22 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
cksf r3jvjrmpnn
21 Aug 15
NEMUS Bioscience Announces Closing of $5.0 Million Series B Financing Funding to finance development of NB1111 for the treatment of glaucoma
12:00am